Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09HBR
|
|||
Former ID |
DIB020452
|
|||
Drug Name |
MS436
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H17N5O3S
|
|||
Canonical SMILES |
CC1=CC(=C(C=C1O)N)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
|
|||
InChI |
1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)
|
|||
InChIKey |
DZTGIRNXWSZBIM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
WikiPathways | Chemical Compounds to monitor Proteins |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. J Med Chem. 2013 Nov 27;56(22):9251-64. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.